Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03860844
Title Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Acronym ISAKIDS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: child
Covered Countries USA | NLD | ITA | FRA | DEU

Facility Status City State Zip Country Details
Sarah Cannon Research Institute-Site Number:8400001 Nashville Tennessee 37203 United States Details
Children's Medical Center of Dallas-Site Number:8400002 Dallas Texas 75235 United States Details
Investigational Site Number :0320002 Caba Buenos Aires C1181ACH Argentina Details
Investigational Site Number :0320006 Capital Federal Buenos Aires C1425DUC Argentina Details
Investigational Site Number :0320005 Buenos Aires C1118AAT Argentina Details
Investigational Site Number :0320004 Buenos Aires C1245AAM Argentina Details
Investigational Site Number :0760013 Curitiba Paraná 80250-060 Brazil Details
Investigational Site Number :0760006 Curitiba Paraná 81520-060 Brazil Details
Investigational Site Number :0760007 Porto Alegre Rio Grande Do Sul 90035 003 Brazil Details
Investigational Site Number :0760010 Jau São Paulo 17210-070 Brazil Details
Investigational Site Number :0760009 Ribeirao Preto São Paulo 14048-900 Brazil Details
Investigational Site Number :0760001 Sao Paulo São Paulo 08270-070 Brazil Details
Investigational Site Number :0760004 Sao Paulo São Paulo 4023-062 Brazil Details
Investigational Site Number :2080001 Copenhagen 2100 Denmark Details
Investigational Site Number :2500002 Lille 59037 France Details
Investigational Site Number :2500003 Lyon 69008 France Details
Investigational Site Number :2500001 PARIS Cedex 12 75571 France Details
Investigational Site Number :2500004 PARIS Cedex 19 75935 France Details
Investigational Site Number :2760005 Erlangen 91054 Germany Details
Investigational Site Number :2760003 Hamburg 20246 Germany Details
Investigational Site Number :2760006 Münster 48149 Germany Details
Investigational Site Number :3000001 Athens 115 27 Greece Details
Investigational Site Number :3480002 Budapest 1094 Hungary Details
Investigational Site Number :3800002 Genova Liguria 16147 Italy Details
Investigational Site Number :3800001 Monza Lombardia 20900 Italy Details
Investigational Site Number :3800003 Torino Piemonte 10126 Italy Details
Investigational Site Number :3800005 Verona Veneto 37126 Italy Details
Investigational Site Number :4100001 Seoul Seoul-teukbyeolsi 03080 Korea, Republic of Details
Investigational Site Number :4100002 Seoul Seoul-teukbyeolsi 06351 Korea, Republic of Details
Investigational Site Number :4100004 Seoul Seoul-teukbyeolsi 137-701 Korea, Republic of Details
Investigational Site Number :4840001 Monterrey Nuevo León 64460 Mexico Details
Investigational Site Number :4840005 Col. Rancho Menchaca Querétaro 76140 Mexico Details
Investigational Site Number :5280001 Utrecht 3584 CS Netherlands Details
Investigational Site Number :5780001 Bergen 5021 Norway Details
Investigational Site Number :5780002 Oslo 0342 Norway Details
Investigational Site Number :6040001 Arequipa Peru Details
Investigational Site Number :6040002 Lima 34 Peru Details
Investigational Site Number :6200002 Coimbra 3000-602 Portugal Details
Investigational Site Number :6200001 Lisboa 1099-023 Portugal Details
Investigational Site Number :6200003 Porto 4200-162 Portugal Details
Investigational Site Number :7520001 Göteborg 416 85 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field